PRETI, PAOLA STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 9.123
AS - Asia 7.482
EU - Europa 6.211
SA - Sud America 731
AF - Africa 187
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 10
Totale 23.755
Nazione #
US - Stati Uniti d'America 8.932
CN - Cina 4.001
SG - Singapore 1.732
IE - Irlanda 1.149
UA - Ucraina 1.080
DE - Germania 933
FI - Finlandia 830
HK - Hong Kong 616
VN - Vietnam 538
BR - Brasile 518
RU - Federazione Russa 507
IT - Italia 490
SE - Svezia 406
FR - Francia 340
GB - Regno Unito 236
IN - India 119
CA - Canada 100
AR - Argentina 78
ZA - Sudafrica 78
BD - Bangladesh 73
IQ - Iraq 67
NL - Olanda 67
MX - Messico 52
PK - Pakistan 41
JP - Giappone 38
TR - Turchia 33
EC - Ecuador 28
SA - Arabia Saudita 27
CL - Cile 26
ES - Italia 26
MA - Marocco 26
VE - Venezuela 25
CO - Colombia 24
PL - Polonia 24
ID - Indonesia 23
MY - Malesia 22
GR - Grecia 21
KE - Kenya 21
PH - Filippine 21
UZ - Uzbekistan 19
RO - Romania 17
BE - Belgio 16
EG - Egitto 14
TN - Tunisia 14
AE - Emirati Arabi Uniti 12
JO - Giordania 12
AZ - Azerbaigian 11
CH - Svizzera 11
TH - Thailandia 11
KZ - Kazakistan 9
PE - Perù 9
CR - Costa Rica 8
EU - Europa 8
IL - Israele 8
NP - Nepal 8
PY - Paraguay 8
UY - Uruguay 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
MU - Mauritius 7
PA - Panama 7
AT - Austria 6
CZ - Repubblica Ceca 6
ET - Etiopia 6
LT - Lituania 6
MK - Macedonia 6
AU - Australia 5
IR - Iran 5
NI - Nicaragua 5
SI - Slovenia 5
SN - Senegal 5
AL - Albania 4
BG - Bulgaria 4
KR - Corea 4
KW - Kuwait 4
OM - Oman 4
QA - Qatar 4
BH - Bahrain 3
CI - Costa d'Avorio 3
HN - Honduras 3
HU - Ungheria 3
LV - Lettonia 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
RS - Serbia 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
BY - Bielorussia 2
DM - Dominica 2
GE - Georgia 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
BF - Burkina Faso 1
Totale 23.737
Città #
Jacksonville 1.347
Chandler 1.310
Dublin 1.148
Nanjing 985
San Jose 922
Singapore 860
Ashburn 637
Hong Kong 603
Dallas 562
Boardman 469
Nanchang 419
Beijing 405
Princeton 393
Munich 339
Hebei 309
Shenyang 288
Lawrence 287
Changsha 274
Wilmington 256
Lauterbourg 252
Helsinki 248
Jiaxing 207
Hangzhou 184
Ho Chi Minh City 184
Tianjin 176
Los Angeles 170
Hanoi 138
Milan 136
Medford 119
Redondo Beach 118
New York 96
Moscow 91
Buffalo 90
Ann Arbor 89
Shanghai 64
Johannesburg 62
Norwalk 57
Woodbridge 51
Cambridge 48
São Paulo 48
Toronto 48
Seattle 43
Kunming 40
Santa Clara 36
Tokyo 36
Da Nang 35
Turku 34
Verona 32
Council Bluffs 31
Baghdad 30
Guangzhou 27
Brooklyn 26
Des Moines 26
Pavia 25
Frankfurt am Main 23
Jinan 23
Stockholm 23
Atlanta 22
Fairfield 22
Montreal 22
Warsaw 22
Chennai 21
Ningbo 21
Boston 20
Haiphong 19
Zhengzhou 19
Orem 18
Tashkent 17
Brussels 16
Chicago 16
Nairobi 16
Rio de Janeiro 16
Mexico City 15
Dhaka 14
Jeddah 14
London 14
Amsterdam 13
Denver 13
Lanzhou 13
Santiago 13
Nuremberg 12
Phoenix 12
San Francisco 12
Baku 11
Changchun 11
Guayaquil 11
Houston 11
Magenta 11
Pune 11
Quito 11
Rome 11
Vancouver 11
Borås 10
Casablanca 10
Istanbul 10
Manchester 10
Mumbai 10
Thái Nguyên 10
Timisoara 10
Amman 9
Totale 15.589
Nome #
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 321
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 290
Anemia in patients with Covid-19: pathogenesis and clinical significance 286
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 248
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. 187
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 172
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 153
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 149
Addition of Manidipine Improves the Antiproteinuric Effect of Candesartan in Hypertensive Patients With Type II Diabetes and Microalbuminuria. 145
Abscisic Acid Treatment in Patients with Prediabetes. 139
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 136
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 131
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 128
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients 127
Atorvastatin-amlodipine combination and fibrinolytic balance in hypertensive hypercholesterolemic insulin-resistent patients 125
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients. 121
Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria 119
Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation. 118
Effect of valsartan amlodipine combination on left ventricular hypertrophy in hypertensive type 2 diabetic patients 117
Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination 116
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 115
Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients 113
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 113
Adding Losartan to Lisinopril Therapy in Patients with Hypertension: Assessment by 24-hour Ambulatory Blood Pressure Monitoring. 113
Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension 108
Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus 108
Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients 108
Beta-blockers effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia 108
Comparative effect of lercanidipine and nifedipine gastrointestinal therapeutic system on ankle volume and subcutaneous interstitial pressure in hypertensive patients:a double-blind, randomized, parallel-group study . 107
Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria. 106
Influence of valsartan and enelapril on cognitive function in elderly hypertensive patients. 106
Early Development of Metabolic Syndrome in Patients Subjected to Lung Transplantation 106
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. 105
Effects of Amlodipine, Nifedipine GITS anf Indomethacin on Angiotensin-converting enzyme inhibitor-induced cough: a randomized, placebo-controlled, double-masked croossover study 104
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation 103
Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients. 102
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 102
Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update 101
A rare case of a patient with hemophilia presenting elbow-ankylosing heterotopic ossification: surgery and functional outcomes. 101
Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients 100
Effect of telmisartan and ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation 100
. Prevalence of primary aldosteronism among unselected hypertensive patients 99
Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. 99
Comparative Efficacy of Losartan and Valsartan in Mild-to-Moderate Hypertension : results of 24-Hour Ambulatory Blood Pressure Monitoring. 99
Confronto tra l'effetto anti-proteinurico dell'associazione telmisartan/amlodipina rispetto a losartan/amlodipina nel paziente con diabete di tipo 2, iperteso e microalbuminurico 97
. Prevalence of primary aldosteronism among hypertensive patients. 97
Effect of amlodipine vs candesartan on left ventricular hypertrophy in hypertensive type 2 diabetic patients 96
Effect of Valsartan and Atenolol on sexual behavior in hypertensive postmenopausal women. 95
Fixed combination of benazepril and low-dose amlodipine in the treatment of mild to moderate essential hypertension: evaluation by 24-hour noninvasive ambulatory blood pressure monitoring 95
Effects of valsartan or ramipril addition to amlodipine/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy 95
Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients 93
. Effects of telmisartan hydrochlorothiazide combination versus nifedipine gits on blood pressure and sympathetic activity in hypertension. 93
Effect of manidipine-rosuvastatin combination on fibrinolysis, inflammation markers and insulin sensitivity in hypertensive hypercholesterolemic patients 92
Effects of valsartan and olmesartan Addition to amlodipine on ankle oedema in hypertensive patients 91
Different effects of aliskiren/hydrochlorotiazide and atenol/hydrochlorotiazide combinations on central pressure in elderly hypertensive patients 91
. Effect of benazepril amlodipine combination on fibrinolysis in hypertensivw diabetic patients. 91
Effect of benazepril amlodipine combination on left ventricular hypertrophy in hypertensive type 2 diabetic patients. 91
Effetto della combinazione valsartan-amlodipina sulla funzione cognitiva in pazienti ipertesi anziani 91
Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men 90
Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients 90
Effect of valsartan on insulin sensitivity and leptin in hypertensive obese patients 90
Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension. 90
Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients 90
Early development of metabolic syndrome in patients subjected to lung transplantation 90
Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus 89
Valsartan amlodipine combination and prevention of atrial fibrillation recurrence in hypertensive diabetic patients 89
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients 89
Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men 89
Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes 89
Effect of aliskiren addition to losartan on fibrinolysis in diabetic hypertensive patients: a three-way crossover study. 89
Comparative study of acipimox and pravastatin in patients with combined hyperlipidemia. 88
Valsartan amlodipine combination and prevention of atrial fibrillation recurrence in hypertensive diabetic patients 88
Prevalence of primary aldosteronism among unselected hypertensive patients 88
Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine 87
Sexual activity and plasma testosterone levels in hypertensive males. 87
Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension 87
Different effects of aliskiren and losartan on fibrinolysis and insulin sensitivity in hypertensive patients with metabolic syndrome 87
Effects of pravastatin given every other day in dyslipidemic hypertensive patients treated with different antihypertensive drugs 86
Effects of insufficient sleep on blood pressure in hypertensive patients: a 24-h study. 86
Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus. 86
Effects of valsartan versus olmesartan addition to amlodipine/hydrochlorothiazide combination in treating stage 2 hypertensive patients 86
Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial 85
Lone paroxysmal atrial fibrillation and inflammatory markers in essential hypertension 85
Effect of telmisartan and ramipril on arial fibrillation episodes recurrence and severity in hypertensive patients with metabolic syndrome and lone paroxysmal atrial fibrillation 85
DIFFERENCE IN INCIDENCE OF COUGH INDUCED BY IMlDAPRlL AND RAMIPRlL: ROLE OF PROSTAGLANDIN SYNTHESIS INHIBITION 85
Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria 85
Effect of valsartan compared to losartan on insulin-resisstance parameters in overweight hypertensive patients 85
Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes. 84
Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine. 84
Effetti dell'associazione valsartan-amlodipina sui marcatori dell'infiammazione, sullo stress ossidativo e sulla dimetilarginina asimmetrica nei pazienti ipertesi con diabete di tipo 2 84
Olmesartan medoxomil: recent clinical and experimental acquisitions 83
Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients 83
Comparative evaluation of telmisartan and eprosartan effect on insulin sensitivity in hypertensive patients with metabolic syndrome 83
Effect of manidipine and nifedipine on plasma active renin and aldosterone in essential hypertensive patients 83
Effects of valsartan or ramipril addition to amlodipine/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy 83
DIFFERENT EFFECTS OF ALISKIREN/IHYDROCHLOROTIAZIDE ANDATENOLOL/lHYDROCHLOROTIAZIDE COMBINATIONS ON CENTRAL PRESSURE IN ELDERLY HYPERTENSIVE PATIENTS 83
Effect of valsartan on adiponectine, leptin and resistine in hypertensive obese patients 82
Effetto del valsartan su adiponectina, leptina e resistina in pazienti ipertesi con obesità 82
Influence of losartan and atenolol on memory function in very elderly hypertensive patients. 82
Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria 82
Totale 10.780
Categoria #
all - tutte 92.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.859


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021625 0 0 0 0 0 0 0 0 0 293 271 61
2021/20221.047 21 7 42 4 8 15 13 75 62 22 191 587
2022/20233.681 413 212 14 315 458 433 0 230 1.400 43 100 63
2023/20241.100 112 194 29 62 200 250 38 111 12 38 23 31
2024/20253.459 38 323 84 140 60 165 296 384 756 50 353 810
2025/20266.903 581 528 786 681 815 368 1.755 290 667 432 0 0
Totale 23.865